SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 258 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 1.12 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $15,588,122 | +116.5% | 98,659 | +77.4% | 2.13% | +110.1% |
| Q1 2024 | $7,199,788 | +91.9% | 55,614 | +43.0% | 1.01% | +67.5% |
| Q4 2023 | $3,751,127 | -38.1% | 38,900 | -22.2% | 0.60% | -45.3% |
| Q3 2023 | $6,061,000 | -58.7% | 50,000 | -61.0% | 1.10% | -51.9% |
| Q2 2023 | $14,692,916 | +142.3% | 128,300 | +191.6% | 2.29% | +126.5% |
| Q1 2023 | $6,064,520 | -93.2% | 44,000 | -91.5% | 1.01% | -87.1% |
| Q4 2020 | $88,655,000 | +33.9% | 520,000 | +10.3% | 7.87% | +20.9% |
| Q3 2020 | $66,212,000 | +235.2% | 471,500 | +282.7% | 6.51% | +250.2% |
| Q2 2020 | $19,754,000 | -21.7% | 123,200 | -52.2% | 1.86% | -41.1% |
| Q1 2020 | $25,238,000 | +39.7% | 258,000 | +84.3% | 3.16% | +112.0% |
| Q4 2019 | $18,066,000 | -3.3% | 140,000 | -43.6% | 1.49% | -48.4% |
| Q3 2019 | $18,682,000 | -25.5% | 248,038 | +50.3% | 2.89% | -15.8% |
| Q2 2019 | $25,072,000 | +186.6% | 165,000 | +124.8% | 3.43% | +329.2% |
| Q1 2019 | $8,749,000 | -31.2% | 73,405 | -37.0% | 0.80% | -44.2% |
| Q4 2018 | $12,716,000 | +3.4% | 116,517 | +53.1% | 1.43% | +1.6% |
| Q3 2018 | $12,293,000 | -35.9% | 76,116 | -47.5% | 1.41% | -46.6% |
| Q2 2018 | $19,179,000 | +4.0% | 145,096 | -41.7% | 2.64% | -5.6% |
| Q1 2018 | $18,448,000 | -13.9% | 248,997 | -35.3% | 2.80% | +11.4% |
| Q4 2017 | $21,421,000 | -11.7% | 384,997 | -28.0% | 2.51% | -27.4% |
| Q3 2017 | $24,267,000 | +87.9% | 534,997 | +39.7% | 3.46% | +57.8% |
| Q2 2017 | $12,913,000 | -9.7% | 383,047 | -20.7% | 2.19% | -21.5% |
| Q1 2017 | $14,298,000 | +31.0% | 483,047 | +21.4% | 2.80% | +1.1% |
| Q4 2016 | $10,918,000 | -32.4% | 398,047 | +51.3% | 2.76% | +5.1% |
| Q3 2016 | $16,154,000 | +814.7% | 263,047 | +378.3% | 2.63% | +1068.9% |
| Q3 2015 | $1,766,000 | -61.3% | 55,000 | -63.3% | 0.22% | -49.7% |
| Q2 2015 | $4,565,000 | +80.3% | 150,000 | -14.3% | 0.45% | +3.7% |
| Q4 2014 | $2,532,000 | +55.3% | 175,000 | +118.8% | 0.43% | -5.1% |
| Q4 2013 | $1,630,000 | – | 80,000 | – | 0.45% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Asymmetry Capital Management, L.P. | 87,180 | $2,581,000 | 3.60% |
| Perceptive Advisors | 1,771,029 | $52,422,000 | 2.99% |
| SPHERA FUNDS MANAGEMENT LTD. | 483,047 | $14,298,000 | 2.80% |
| HealthCor Management, L.P. | 1,550,000 | $45,880,000 | 2.10% |
| Camber Capital Management LP | 1,350,000 | $39,960,000 | 1.62% |
| Tourbillon Capital Partners, L.P. | 1,537,518 | $45,511,000 | 1.17% |
| Elk Creek Partners, LLC | 562,522 | $16,651,000 | 1.02% |
| EMERALD ADVISERS, LLC | 818,705 | $24,234,000 | 1.00% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 604,467 | $17,892,000 | 0.82% |
| Carlson Capital, L.P. | 1,845,702 | $54,633,000 | 0.70% |